Accolade for CAPRISA’s Research Pharmacist
C APRISA’s Senior Research Pharmacist, Ms Anushka Naidoo, scooped the best presenta-tion award at the 19th International Confer-ence on Tuberculosis Therapy (ICTT 2017), hosted by the World Academy of Science, Engineering and Technology. Her presentation focussed on the effect of rifampicin and efavirenz on moxifloxacin concen-trations when co-administered in patients with drug susceptible tuberculosis (published in the Journal of Antimicrobial Chemotherapy 2017:doi:10.1093/jac/dkx004).
The study was conducted within the Improving Retreatment Success Clinical (IMPRESS) trial, which compared the pharmacokinetics of moxifloxa-cin during co-treatment with rifampicin or when dosed alone in African patients with drug suscepti-ble, recurrent tuberculosis, the majority of whom were HIV co-infected and on efavirenz-based ART. "The conference was a really great opportunity to share our study findings with the TB research community," said Naidoo. She said receiving the best presentation award "was really exciting and an hon-our for myself and the study team."
The ICTT is considered the premier interdisciplinary forum for the presentation of new advances and research results in the field of tuberculosis therapy.